Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Prostate cancer (PCa) patients present at the Urology Clinic of the Second Hospital of Tianjin Medical University. 2. PCa Patients who were pathologically diagnosed through prostate biopsy or postoperative results, or clinically diagnosed based on imaging and other data due to contraindication of puncture or surgery. 3. Accept the baseline cardiovascular health assessment. 4. Perform a serum prostate-specific antigen (PSA) test and agree to keep the remaining blood samples. 5. Good compliance and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with other types of tumors. 2. Patients who were considered unsuitable to participate in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiovascular events (MACE; non-fatal stroke, non-fatal myocardial infarction, or cardiovascular death); | — |
Secondary
| Measure | Time frame |
|---|---|
| Prostate cancer related death;All-cause death;Electrocardiogram;Metabonomics; | — |
Countries
China
Contacts
The Second Hospital of Tianjin Medical University